Health officials issue safety alert on unapproved stem cell products after Nebraska outbreak

December 10, 2019
Officials from the Nebraska Department of Health and Human Services have issued a public health advisory following multiple reports of serious…

Feature

Podcasts driving a revolution in rheumatology medical education

December 6, 2019
When journalist Ben Hammersley coined the word “podcast” in 2004, he was attempting to put a name to the phenomenon resulting from the…

Meeting News

One-year delay in diagnosis common for Down syndrome arthropathy

November 29, 2019
ATLANTA — Patients with Down syndrome arthropathy experience a year-long delay from symptom onset to diagnosis, according to a presentation at…

Meeting News

ADA2 levels elevated in systemic JIA with macrophage activation syndrome

November 26, 2019
ATLANTA — Systemic juvenile idiopathic arthritis with macrophage activation syndrome was marked by elevated adenosine deaminase 2 levels…

Meeting NewsPerspective

Absence of pediatric studies blocking critical biologic DMARDs for JIA

November 25, 2019
ATLANTA — Lax FDA policies on required pediatric studies for approved biologic DMARDs have exacerbated an already critical lack of approved…

Meeting News

Exposure to TNF inhibitors increases psoriasis risk in children with IBD, JIA

November 25, 2019
Children with inflammatory bowel disease, juvenile idiopathic arthritis and chronic noninfectious osteomyelitis had an increased rate of psoriasis…

Meeting News

Intervention bundle improves flu vaccination rates in RA/JIA patients

November 21, 2019
ATLANTA — An intervention bundle reminding patients with rheumatoid arthritis and juvenile idiopathic arthritis of the benefits of influenza…

Meeting News

Mitochondrial abnormalities a prognostic marker for juvenile dermatomyositis

November 20, 2019
ATLANTA — Patients with juvenile dermatomyositis demonstrate obvious mitochondrial abnormalities in the tissue and periphery, supporting the…

Meeting News

Tofacitinib bested placebo for disease flares in polyarticular JIA

November 19, 2019
ATLANTA — Results of a double-blind, randomized, placebo-controlled trial showed a clear benefit of tofacitinib in controlling disease flares…

Meeting News

Children with Down syndrome have higher risk for arthritis, delayed diagnosis

November 19, 2019
ATLANTA — Children with Down syndrome are at an increased risk for arthritis at a rate that is two to three times higher than previously…

FDA News

FDA approves Abrilada, fifth Humira biosimilar

November 18, 2019
The FDA has approved Abrilada, a biosimilar to Humira, making it the fifth biosimilar to the reference drug and 25th biosimilar overall to gain…

Meeting News

Poor health literacy, wait times drive influenza vaccine hesitancy in RA, JIA

November 18, 2019
ATLANTA — Limited knowledge about inactivated vaccines, misconceptions and fears, as well as long wait times and accessibility issues are among…

In the Journals

Psoriasis risk spikes with anti-TNF use in children with inflammatory diseases

November 6, 2019
Children with either inflammatory bowel disease, chronic noninfectious osteomyelitis or juvenile idiopathic arthritis developed psoriasis at an…

In the Journals

Parenchymal lung disease reported in systemic juvenile idiopathic arthritis

October 31, 2019
Acute digital clubbing was one clinical characteristic of a rare and potentially fatal lung disease recently observed in a cohort of patients with…

In the JournalsPerspective

Cancer, infection risk higher among patients treated with IL inhibitors

October 29, 2019
Rheumatology patients treated with interleukin inhibitors have an increased risk for serious infections, opportunistic infections and cancer…

In the Journals

Coronary artery disease risk higher among adults with prior juvenile arthritis

October 28, 2019
Adults with a history of juvenile arthritis carry a greater risk for coronary artery disease compared with those without arthritis, according to data…

In the Journals

Written, verbal patient education prior to biosimilar switching recommended for JIA

October 28, 2019
Rheumatology practices should provide written and verbal patient education, and supply adequate teaching for all staff, prior to nonmedical…

In the JournalsPerspective

Most physical therapists correctly identify inflammatory arthritis, refer to rheumatologists

October 22, 2019
The majority of physical therapists can accurately distinguish between inflammatory and noninflammatory arthritis and understand the importance of…

In the Journals

Checkpoint inhibitor induced inflammatory arthritis persists after discontinuation

October 10, 2019
Inflammatory arthritis caused by immune checkpoint inhibitor therapy can develop into a long-term condition even after treatment cessation, requiring…

In the JournalsPerspective

Adalimumab well-tolerated by most children with polyarticular JIA

September 5, 2019
Adalimumab, with or without methotrexate, is well-tolerated over a period of at least 7 years among most children with polyarticular-course juvenile…